title: New antimicrobial combinations: substituted chalcones- oxacillin against methicillin resistant Staphylococcus aureus.
abstract: Staphylococcus aureus, the most virulent Staphylococcus species, is also the prevalent pathogen isolated from hospitalized patients and the second most common from patients in outpatient settings. In general, bacteria have the genetic ability to transmit and acquire resistance to drugs, which are utilized as therapeutic agents. Related studies of antimicrobial activity indicate that crude extracts containing flavonoids, triterpenes and steroids have showed significative activity against several Staphylococcus aureus strains. Combination effects between flavonoids and antibiotics also have been reported. The aim of the present work was to investigate in vitro synergism between several chalcones substituted in combination with oxacillin, an antibiotic used conventionally against S. aureus ATCC 43 300 that is resistant to meticillin, using the kinetic turbidimetric method developed earlier. The results were satisfactory for all assayed combinations and in accordance with the mechanism of bacteriostatic inhibition previously proposed, except for 2´,4´-dihydroxy-3´-methoxychalcone - oxacillin. The best combination was 2´,3´-dihydroxychalcone -oxacillin (MIC: 11.2 µg/mL). Further investigations are needed to characterize the interaction mechanism with antibiotics. Thus, chalcones - oxacillin combination could lead to the development of new antibiotics against methicillin resistant S. aureus infection.
authors.affiliation: Laboratory of Physical Chemistry, Department of Chemistry, San Luis National University , Lavalle 1155. 5700 San Luis , Argentina.
authors.forename: Juan Manuel
authors.initials: JM
authors.lastname: Talia
authors.forename: Nora Beatriz
authors.initials: NB
authors.lastname: Debattista
authors.forename: Nora Beatriz
authors.initials: NB
authors.lastname: Pappano
keywords: S. aureus; antimicrobial; combinations; oxacillin; substituted chalcones
references.citation: J Biotechnol. 2005 Mar 30;116(3):295-304
references.pmid: 15707690
references.citation: Phytother Res. 2007 Jan;21(1):32-6
references.pmid: 17072829
references.citation: Inflammation. 2009 Apr;32(2):99-108
references.pmid: 19214725
references.citation: Bioorg Med Chem. 2006 May 1;14(9):2966-71
references.pmid: 16412650
references.citation: Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5125-31
references.pmid: 17962465
references.citation: Lab Invest. 2007 Jan;87(1):3-9
references.pmid: 17146447
references.citation: Phytochemistry. 2007 Apr;68(8):1179-88
references.pmid: 17395220
references.citation: J Agric Food Chem. 2004 Jan 28;52(2):255-60
references.pmid: 14733505
references.citation: Int J Antimicrob Agents. 2004 Sep;24(3):226-33
references.pmid: 15325425
references.citation: J Antimicrob Chemother. 2009 Sep;64 Suppl 1:i3-10
references.pmid: 19675017
references.citation: J Appl Microbiol. 2007 Dec;103(6):2056-64
references.pmid: 18045389
references.citation: Antimicrob Agents Chemother. 2005 Feb;49(2):549-55
references.pmid: 15673731
references.citation: Int J Antimicrob Agents. 2004 Sep;24(3):241-6
references.pmid: 15325427
references.citation: J Steroid Biochem Mol Biol. 2005 Apr;94(5):431-43
references.pmid: 15876408
references.citation: Folia Microbiol (Praha). 2008;53(1):23-8
references.pmid: 18481214
references.citation: N Engl J Med. 1998 Aug 20;339(8):520-32
references.pmid: 9709046
references.citation: J Ethnopharmacol. 2005 Oct 3;101(1-3):334-7
references.pmid: 16029939
references.citation: Lancet Infect Dis. 2005 May;5(5):275-86
references.pmid: 15854883